Natco Pharma Launches Generic Drug in US

1 Minute Read Listen to Article
Share:    

Aug 20, 2025 14:27

x
Natco Pharma launches generic Bosentan tablets for pulmonary hypertension in the US with 180-day exclusivity. Partnering with Lupin Ltd.
Natco Pharma Launches Generic Drug in US
Photograph: Yves Herman/Reuters
New Delhi, Aug 20 (PTI) Natco Pharma on Wednesday said it has launched a generic medication to treat high blood pressure in the lungs in the US with 180-day exclusivity.

The company has launched Bosentan tablets for oral suspension (32 mg), a generic version of Tracleer tablets by Actelion Pharmaceuticals US Inc.

Natco's marketing partner for the product is Lupin Ltd, the Hyderabad-based drug maker said in a regulatory filing.


Natco holds the first-to-file status for this product and will have 180-day generic drug exclusivity, it added.

The drug is indicated for the treatment of pulmonary arterial hypertension (PAH) in paediatric patients aged 3 years and older.

Bosentan tablets for oral suspension (32 mg) had estimated sales of USD 10 million in the US for 12 months ended June this year, as per industry sales data, Natco Pharma stated.

Shares of the drug firm were trading 0.53 per cent down at Rs 888.55 apiece on the BSE.
Share:    

TODAY'S MOST TRADED COMPANIES

  • Company Name
  • Price
  • Volume

See More >

Moneywiz Live!

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback